Quinidine: an “Endangered Species” Drug Appropriate for Management of Electrical Storm in Brugada Syndrome

• Main Authors: Stelios Paraskevaidis, MD, PhD, Efstratios K. Theofilogiannakos, MD, PhD, Vasileios Kamperidis, MD, Yiannis S. Chatzizisis, MD, PhD, Konstantinos Tsilonis, MD, Vassilios P. Vassilikos, MD, PhD, George Dakos, MD, PhD, George Stavropoulos, MD, Antonios Ziakas, MD, PhD, Stavros Hadjimiltiades, MD, PhD, Ioannis H. Styliadis, MD, PhD
• Format: Article
• Language: English
• Published: Elsevier 2013-09-01
• Series: Indian Pacing and Electrophysiology Journal
• Subjects: Brugada syndrome; electrical storm; quinidine
• Online Access: http://www.sciencedirect.com/science/article/pii/S0972629216306702
• ISSN: 0972-6292

Brugada syndrome is an inherited channelopathy associated with an increased risk of syncope and sudden cardiac death. In rare cases it can be manifested with electrical storm. We report two cases of Brugada syndrome that presented with electrical storm and were treated successfully with oral quinidine, an "endangered species" drug.